Amphastar: Fourth Quarter Financial Overview

Amphastar Pharmaceuticals Announces Fourth-Quarter Financial Results

Amphastar Pharmaceuticals Inc., headquartered in Rancho Cucamonga, California, disclosed a net profit of $24.4 million for the fourth quarter.

The company reported earnings of $0.51 per share, while adjusted earnings—excluding special items—were $0.73 per share.

These figures did not meet analyst expectations, as the consensus from three analysts surveyed by Zacks Investment Research had anticipated earnings of $0.97 per share.

During the quarter, Amphastar generated $183.1 million in revenue.

For the full year, the company achieved a net income of $98.1 million, or $2.03 per share, with total revenue reaching $719.9 million.

Since the start of the year, Amphastar’s stock price has declined by 1%. As of the close of trading on Thursday, shares were valued at $26.49, reflecting a 15% decrease over the past year.

Financial data for this article was provided by Zacks Investment Research and compiled by Automated Insights.